Skip to main content

View full-text article in PMC

. 2018 Oct 23;9:2443. doi: 10.3389/fimmu.2018.02443

Table 1.

Clinical data corresponding to HIV⁺ subjects enrolled per study group.

				CD4 count		CD4/CD8
ID^a	Time to cART (months)^b	Time on cART (months)^c	Pre-treatment Viral Load^d^,^e	Before cART^d^,^f	On cART^f^,^g	Before cART^d^,^f	On cART^f^,^g
DT1	50	22	48526	383	524	0.72	1.35
DT2	22	18	132317	324	297	0.46	0.52
DT3	8	18	125716	391	711	0.48	0.65
DT4	11	5	27244	465	535	0.45	0.74
DT5	25	5	4612	408	739	0.48	1.00
DT6	19	15	66929	246	501	0.24	0.62
DT7	50	5	15297	330	468	0.42	0.77
DT8	5	12	>500000	279	528	0.26	0.72
DT9	21	14	28288	184	579	0.30	0.88
DT10	13	20	1702	357	563	0.44	0.72
DT11	22^*	12	10033	819	819	0.88	1.36
DT12	9	8	111893	629	880	0.85	1.53
ET1	2	14	>500000	627	594	0.66	0.89
ET2	4	18	283441	187	522	0.20	0.88
ET3	1	11	36338	768	1099	1.18	1.83
ET4	3	14	17292	612	1342	0.33	1.32
ET5	3	15	20106	787	829	1.06	1.69
ET6	2	18	>500000	421	854	0.31	1.89
ET7	1	13	>500000	435	942	0.13	1.52
ET8	3	12	172468	435	657	0.59	1.16
ET9	3	17	26547	400	728	0.70	1.79
ET10	3^*	11	231360	330	1080	0.18	1.24
ET11	2	12	>500000	654	1026	0.42	1.47
ET12	4	16	>500000	339	691	0.08	0.66
ET13	4	12	>500000	213	386	0.19	0.81

^a

DT, Delayed Treatment Group; ET, Early Treatment Group.

^b

Relative to the presumed date of infection.

^c

Time from the moment of cART initiation to sample obtaining.

^d

Determinations evaluated at the closest sample obtained before cART initiation.

^e

Versant HIV-1 RNA 3.0 assay, Siemens. Lower and upper detection limits are 50 and 500,000 RNA copies/ml, respectively (1.7 and 5.7 log₁₀).

^f

Determined by flow cytometry.

^g

Determinations evaluated in samples used in this study.

^*

Estimated time to cART initiation, as informed by the clinician.